Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study.

Dacic, Sanja; Travis, William D; Giltnane, Jennifer M; Kos, Filip; Abel, John; Hilz, Stephanie; Fujimoto, Junya; Sholl, Lynette; Ritter, Jon; Khalil, Farah; Liu, Yi; Taylor-Weiner, Amaro; Resnick, Murray; Yu, Hui; Hirsch, Fred R; Bunn, Paul A; Carbone, David P; Rusch, Valerie; Kwiatkowski, David J; Johnson, Bruce E; Lee, Jay M; Hennek, Stephanie R; Wapinski, Ilan; Nicholas, Alan; Johnson, Ann; Schulze, Katja; Kris, Mark G; Wistuba, Ignacio I

Dacic, Sanja; Travis, William D; Giltnane, Jennifer M; Kos, Filip; Abel, John; Hilz, Stephanie; Fujimoto, Junya; Sholl, Lynette; Ritter, Jon; Khalil, Farah; Liu, Yi; Taylor-Weiner, Amaro; Resnick, Murray; Yu, Hui; Hirsch, Fred R; Bunn, Paul A; Carbone, David P; Rusch, Valerie; Kwiatkowski, David J; Johnson, Bruce E; Lee, Jay M; Hennek, Stephanie R; Wapinski, Ilan; Nicholas, Alan; Johnson, Ann; Schulze, Katja; Kris, Mark G; Wistuba, Ignacio I.

Affiliation

Dacic S; Department of Pathology, Yale School of Medicine, New Haven, Connecticut. Electronic address: sanja.dacic@yale.edu.
Travis WD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Giltnane JM; Research Pathology, Genentech, Inc., South San Francisco, California.
Kos F; Department of Machine Learning, PathAI, Inc., Boston, Massachusetts.
Abel J; Department of Machine Learning, PathAI, Inc., Boston, Massachusetts.
Hilz S; Research Pathology, Genentech, Inc., South San Francisco, California.
Fujimoto J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sholl L; Department of Anatomic Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Ritter J; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.
Khalil F; Department of Pathology, Moffitt Cancer Center, Tampa, Florida.
Liu Y; Department of Machine Learning, PathAI, Inc., Boston, Massachusetts.
Taylor-Weiner A; Department of Machine Learning, PathAI, Inc., Boston, Massachusetts.
Resnick M; Department of Pathology, PathAI, Inc., Boston, Massachusetts.
Yu H; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Hirsch FR; Department of Hematology and Medical Oncology, University of Colorado/Icahn School of Medicine, Mount Sinai, New York.
Bunn PA; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Carbone DP; Division of Medical Oncology, The Ohio State University Medical Center and Pelotonia Institute for Immuno-Oncology, Columbus, Ohio.
Rusch V; Thoracic Surgery Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Kwiatkowski DJ; Department of Anatomic Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Johnson BE; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Lee JM; Division of Thoracic Surgery, University of California, Los Angeles, Los Angeles, California.
Hennek SR; Department of Translational Research, PathAI, Inc., Boston, Massachusetts.
Wapinski I; Department of Translational Research, PathAI, Inc., Boston, Massachusetts.
Nicholas A; U.S. Medical Affairs, Genentech, Inc., South San Francisco, California.
Johnson A; U.S. Medical Affairs, Genentech, Inc., South San Francisco, California.
Schulze K; Research Pathology, Genentech, Inc., South San Francisco, California.
Kris MG; Department of Thoracic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.